Welcome : Guest

ORGAN AND TISSUE TRANSPLANTATION - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Organ and Tissue Transplantation in number of organs transplanted. The Global and regional markets (except the US) for ‘Organ and Tissue Transplantation’ in this report are analyzed by the following Product Segments - Organ Tranplantation (Heart, Kidneys, Liver, Pancreas, Lungs, and Corneal Transplantation). The US market for ‘Organ and Tissue Transplantation’ in this report is analyzed by the following Product Segments: Organ Type (In Volume and Value) (Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine), Tissue Type (Volume Only) (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), and Bone Graft Transplantation (Volume Only) (By Graft Type: Autologous Graft, Allograft, and Other Materials; By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 22 companies including many key and niche players such as -

Acelity L.P. Inc.
CryoLife, Inc.
Exactech, Inc.
Folio Biosciences, LLC
Dr. Franz Kohler Chemie GmbH

Click here to request a full list of companies covered in the report...

Code: MCP-1572
Price: $4950
Companies: 22
Pages: 266
Date: November 2016
Market Data Tables: 130
 



TABLE OF CONTENTS


  ORGAN AND TISSUE TRANSPLANTATION (Complete Report) Pages : 266   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definition and Scope of Study.....I-3  
   Market Outlook.....II-11$100
   Current & Future Analysis.....II-21$100
   A Review of Organ Donors Worldwide.....II-3
Table 1: Global Organ Transplants Market (2014 & 2015): Number of Deceased Organ Donors per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart).....II-3

Table 2: Global Organ Transplants Market (2014 & 2015): Number of Living Organ Donors per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart).....II-3
1$350
   Kidney and Liver Transplants Top the Organ Transplants Worldwide.....II-4
Table 3: Global Kidney Transplants Market (2014): Number of Deceased Donors Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart).....II-4
1$350
   Table 4: Global Kidney Transplants Market (2014): Number of Living Donors Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart).....II-5

Table 5: Global Liver Transplants Market (2014): Number of Deceased Donors Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart).....II-5
1$350
   Table 6: Global Liver Transplants Market (2014): Number of Living Donors Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart).....II-6

Table 7: Global Heart Transplants Market (2014): Number of Transplants Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart).....II-6
1$350
   Table 8: Global Lung Transplants Market (2014): Number of Transplants Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart).....II-7

Table 9: Global Pancreas Transplants Market (2014): Number of Transplants Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart).....II-7
Demand and Supply Imbalance.....II-7
1$350
   Measures to Address Organ Shortage .....II-8
Cardiac Arrest Death Patients: The Untapped Potential Donors.....II-8
Table 10: Global Organ Transplants Market (2014): Number of Actual Donors After Cardiac Death per Million Population (PMP) by Select Country (includes corresponding Graph/Chart).....II-8
1$350
   Donation after Circulatory Death – Rife with Ethical Issues.....II-9
Transplantation – Expenditure and Regional Variations.....II-9
Table 11: US Organ Transplantation Charges - Total Billed Charges per Transplant by Type (2014) (includes corresponding Graph/Chart).....II-9
2$350
   Bone Grafts: An Overview.....II-11
Table 12: Fractures by Age Group (2014): Percentage Share Breakdown of Number of Fractures by Age Group (includes corresponding Graph/Chart).....II-11
1$350
   Table 13: Global Orthopedic Market by Segment (2015E): Percentage Breakdown of Value Sales for Extremities, Hips, Knees, Orthobiologics, Spine, Trauma and Others (includes corresponding Graph/Chart).....II-12
Orthopedic Grafts – Regional Market Variations.....II-12
1$350
   Combined Organ Transplantation – Gaining Attention.....II-13
Table 14: Multiple Organ Transplants in the US - No. of Transplants by Type (2014- 2016) (includes corresponding Graph/Chart).....II-13
1$350
   Illegal Organ Trafficking – A Risky Proposition.....II-14
Transplant Tourism – Creating Brighter Avenues.....II-14
Graying Population and Chronic Diseases Surge Need for Transplants.....II-14
1$100
   Global Aging Population Statistics – Opportunity Indicators.....II-15
Table 15: Elderly Population (60+ Years) as a Percentage of Total Population (2015 & 2050) (includes corresponding Graph/Chart).....II-15
1$350
   Table 16: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart).....II-161$350
   Table 17: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart).....II-171$350
   Table 18: Life Expectancy for Select Countries in Number of Years: 2015E (includes corresponding Graph/Chart).....II-18
Optimization Strategies for Organs Catch Attention and Supply-Demand Gap
  Widens.....II-18
1$350
   Advent of Innovative Devices Mitigate Chances of Organ Damages.....II-191$100
   Shortage of Organs Propels Research on Xenotransplantation.....II-201$100
   A Peek into the Organ Transplant Immunosuppressants Market.....II-211$100
   Market to Come Under Tremendous Pressure.....II-22
Rising Incidences of Degenerative Intervertebral Disc Diseases Promote Tissue
  Transplantation.....II-22
1$100
   Table 19: % of Women Affected by Osteoporosis (includes corresponding Graph/Chart).....II-23
Fetal Tissue for Bionic Devices – Assuming Importance.....II-23
LVADs – Gaining Significance for Impending Heart Transplants.....II-23
Synthetic Bone Graft – The Latest Trend.....II-23
1$350
   Stem Cell Therapies – Expanding the Horizon of Transplantation.....II-241$100
   Rising Cancer Incidence to Drive Stem Cell Transplants.....II-25
Table 20: Number of New Cancer Cases Worldwide by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart).....II-25
1$350
   Demineralized Bone Matrix (DBM): Strong Growth but Tough Competition.....II-26
Bone Morphogenetic Protein – Safety Concerns Affect Growth Prospects.....II-26
Dental Bone Grafting – A High Potential Market.....II-26
1$100
   Table 21: Dental Tissue & Bone Regeneration Materials Market (2015): Percentage Share Breakdown by Segment for Allografts, Synthetics, and Xenografts (includes corresponding Graph/Chart).....II-27
Key Recent Technological Innovations.....II-27
3-D Bioprinting.....II-27
1$350
   Preloaded Corneal Tissue Cartridges.....II-28
Lung Perfusion Technology.....II-28
1$100
   Organ Rejection – A Major Barrier to Transplantation.....II-29
Scarcity of Donor Organs – A Stumbling Block in Organ Transplantation.....II-29
Other Issues for Organ Transplantation.....II-29
Ethical Concerns in Transplants.....II-29
1$100
   Bioethical Issues Hinder Organ Donation Process.....II-30
Lack of Requisite Expertise – Hindering Implantation Process.....II-30
Corneal Transplantation in Developing Countries: Key Challenges.....II-30
1$100
   Organ and Tissue Transplantation.....II-31
Organ Transplantation.....II-31
Heart Transplantation.....II-31
1$100
   Heart Diseases and Disorders.....II-32
Post-Operative Complications and Consequences of Heart Transplants.....II-32
Bleeding.....II-32
Infection.....II-32
Arrhythmia.....II-32
Heart Attack.....II-32
1$100
   Coronary Artery Disease.....II-33
Respiratory Dysfunction.....II-33
Renal Dysfunction.....II-33
Graft Rejection and Dysfunction.....II-33
Death.....II-33
Kidney Transplantation.....II-33
1$100
   Kidney Disorders and Diseases.....II-34
Donor Evaluation.....II-34
Waiting List.....II-34
Surgery/Post-Operation.....II-34
Post-Operative Supervision and Issues.....II-34
1$100
   Liver Transplantation.....II-35
Liver Disorders and Diseases.....II-35
1$100
   Pancreas Transplantation.....II-36
Post-Operative Complications and Consequences of Pancreas Transplants.....II-36
1$100
   Small Intestine Transplantation.....II-37
Intestine Disorders and Diseases.....II-37
Lung Transplantation.....II-37
Lung Diseases and Disorders.....II-37
1$100
   Lung Patients Survival Statistics.....II-38
Heart-and-Lung Transplantation.....II-38
Tissue Transplantation.....II-38
Types of Grafts.....II-38
Autograft.....II-38
1$100
   Allograft / Homograft.....II-39
Transplant Tolerance.....II-39
Isograft.....II-39
Xenograft.....II-39
1$100
   Corneal Transplantation.....II-40
Penetrating Keratoplasty.....II-40
1$100
   Lamellar (Non-Penetrating) Keratoplasty.....II-41
Aftercare.....II-41
Risks Associated with Corneal Transplants.....II-41
Transplantation Outcomes.....II-41
Morbidity and Mortality Rates.....II-41
1$100
   Alternatives.....II-42
Blood Stem Cells.....II-42
Peripheral Blood Stem Cell Transplant.....II-42
Umbilical Cord Blood Stem Cell Transplant.....II-42
Bone Marrow and Hematopoietic Stem Cells.....II-42
Bone and Tissue Transplantation.....II-42
1$100
   Bone Marrow Transplants.....II-43
Stem Cell Therapy.....II-43
1$100
   Human Heart Valves.....II-44
Atrioventricular Valves.....II-44
Mitral Valve.....II-44
Tricuspid Valve.....II-44
Semilunar Valves.....II-44
1$100
   Aortic Valve.....II-45
Pulmonic Valve.....II-45
Pathology of Valves.....II-45
Prosthetic Heart Valves.....II-45
1$100
   Prosthetic Mechanical Valve.....II-46
Advantages.....II-46
Disadvantages.....II-46
Prosthetic Biologic Valve.....II-46
1$100
   Advantages.....II-47
Disadvantages.....II-47
Fetal Cells.....II-47
Fetal Tissue for Transplantation.....II-47
1$100
   Storage Duration Time.....II-48
Storage Time Period for Organs and Tissues.....II-48
Cold Ischemia Time.....II-48
Transplantation Immunology.....II-48
Acute Cellular Rejection.....II-48
1$100
   Chronic Rejection.....II-49
Post-Transplant Observations.....II-49
Types of Donors.....II-49
Alive Donors.....II-49
Related Donors.....II-49
1$100
   Good Samaritans.....II-50
Rewarded/Forced Donors.....II-50
Deceased Donors.....II-50
Directed / Allocated.....II-50
Organs and Tissues Transplanted by Type of Donor.....II-50
1$100
   Organ/Tissue Donation and Eligibility Criteria.....II-51
Factors Considered for Matching Recipients to Donor Organs.....II-51
Testing.....II-51
Blood Typing.....II-51
1$100
   Tissue Typing.....II-52
Histocompatibility – A Major Barrier for Organ Transplantation.....II-52
1$100
   Transplantation – Safety Requirements.....II-53
Waiting List.....II-53
Active Waiting List Patients.....II-53
Inactive Waiting List Patients.....II-53
History.....II-53
2$200
   Major Milestones in Organ Transplantation.....II-551$100
   Artificial Organs Revolutionize Medical Technology Industry.....II-56
Artificial Organs.....II-56
Categorization of Artificial Organs.....II-56
1$100
   External Artificial Organs.....II-57
Internal or Implantable Artificial Devices.....II-57
Artificial Heart.....II-57
Total Artificial Heart (TAH).....II-57
Ventricle Assist Device (VAD).....II-57
Right Ventricular Assist Systems (RVAS).....II-57
Left Ventricular Assist Systems (LVAS).....II-57
1$100
   Select Ventricular Assist Devices.....II-58
Artificial Kidney (Dialyzer).....II-58
Limitations of Artificial Kidney.....II-58
1$100
   Artificial Liver.....II-59
Select Liver Assist Devices.....II-59
Categorization of Liver Devices.....II-59
Mechanical Systems.....II-59
Bio-Artificial Systems.....II-59
Artificial Pancreas.....II-59
1$100
   Artificial Lungs (Oxygenator).....II-60
Types of Artificial Lung.....II-60
Artificial Cornea.....II-60
Keratoprostheses.....II-60
Tissue Engineered Corneas.....II-60
Artificial Skin/Skin Replacement Products.....II-60
AlloDerm Regenerative Tissue Matrix.....II-60
1$100
   Apligraf.....II-61
Cymetra Micronized AlloDerm Tissue.....II-61
Dermagraft.....II-61
Epicel.....II-61
Integra Products.....II-61
OrCel.....II-61
TransCyte.....II-61
1$100
   Core Competitive Factors.....II-62
Market Outlook for Artificial Organs.....II-62
1$100
   Organ Preservation Solutions.....II-63
Celsior Solution.....II-63
Collins Solution.....II-63
Euro Collins Solution.....II-63
Custodiol® HTK Solution.....II-63
Hypothermosol.....II-63
1$100
   ViaSpan.....II-64
Immunosuppressant Drugs.....II-64
Antibody Products for Treatment of Organ Transplant Rejection.....II-64
Antithymocyte Globulin.....II-64
ATGAM.....II-64
1$100
   Thymoglobulin.....II-65
Therapeutic Antibody Products.....II-65
Antiproliferative Agents.....II-65
Azathioprine.....II-65
CellCept.....II-65
Certican.....II-65
Myfortic.....II-65
Calcineurin Inhibitors.....II-65
1$100
   Cyclosporine.....II-66
Gengraf.....II-66
Neoral.....II-66
Prograf (Tacrolimus).....II-66
TOR Inhibitors.....II-66
Side Effects of Immunosuppression Therapy.....II-66
1$100
   Transplant Center.....II-67
Organ Procurement Organization (OPO).....II-67
Health Resources and Services Administration (HRSA).....II-67
Division of Transplantation (DoT).....II-67
United Network for Organ Sharing (UNOS).....II-67
Organ Procurement and Transplantation Network (OPTN).....II-67
1$100
   University Renal Research and Education Association (URREA).....II-68
Scientific Registry of Transplant Recipients (SRTR).....II-68
Funding Sources.....II-68
Patient Education and Advocacy Organizations.....II-68
1$100
   Legal Framework for Transplantation.....II-69
Legislation Covering Organ Transplant.....II-69
Organ Transplantation and Ethics.....II-69
2$200
   Paragonix Technologies and Waters Medical Systems Enter into Product Supply
  Agreement.....II-71
Medtronic Announces Availability of Beacon Heart Failure Management Service.....II-71
Paragonix Technologies and Essential Pharmaceuticals Enter into Product Supply
  Agreement.....II-71
LeMaitre Vascular Acquires ProCol® Distribution Rights and Purchase Option.....II-71
Merit Medical Systems Purchases HeRO Graft Product Line of CryoLife.....II-71
1$100
   CryoLife Takes Over On-X Life Technologies.....II-72
Medtronic Obtains FDA Clearance on Infuse® Bone Graft.....II-72
Veloxis Pharmaceuticals Introduces Envarsus® XR for Kidney Transplant
  Treatment.....II-72
Organogenesis Obtains Marketing Authorization on Apligraf® Wound Healing
  Technology.....II-72
Medtronic Plc Introduces Medtronic CoreValve® System for Everyday Clinical
  Experience.....II-72
1$100
   Genomic Data Sciences Releases Unique Human Leukocyte Antigen (HLA) Typing Software
  Solution.....II-73
St. Jude to Acquire Thoratec.....II-73
Lifeline Scientific Obtains CFDA Clearance for Commercial Sale of Clinical Organ
  Preservation and Flush Solutions.....II-73
Organovo and Yale Team Up to Develop Bioprinted Tissues for Surgical
  Transplantation.....II-73
ThermoGenesis and TotipotentRX Complete 20th Pediatric BMT.....II-73
LifeCell Acquires Adipose Tissue Injector from Tau Tona Group.....II-73
1$100
   AlloSource Introduces AlloMend™.....II-74
Synergy Biomedical Launches Bonegraft Product BioSphere Putty.....II-74
K2M Launches Venado Bonegraft Systems.....II-74
OTS Launches LifeCradle® Heart Perfusion System.....II-74
FBiH Signs Agreement with Croatia.....II-74
AlloSource and HumaCyte Enter Manufacturing Agreement.....II-74
PSF Partners with MTF for Research Grants.....II-74
1$100
   Acelity L.P. Inc. (US).....II-75
CryoLife, Inc. (US).....II-75
1$100
   Exactech, Inc. (US).....II-76
Folio Biosciences, LLC (US).....II-76
Dr. Franz Kohler Chemie GmbH (Germany).....II-76
Medtronic, plc. (Ireland).....II-76
1$100
   Organogenesis, Inc. (US).....II-77
Organ Recovery Systems (US).....II-77
Organ Transport Systems (US).....II-77
1$100
   XVIVO Perfusion AB (Sweden).....II-781$100
   Table 22: World Recent Past, Current & Future Analysis for Organ Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-791$350
   Table 23: World Historic Review for Organ Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-801$350
   Table 24: World 14-Year Perspective for Organ Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-811$350
   Table 25: World Recent Past, Current & Future Analysis for Heart Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-821$350
   Table 26: World Historic Review for Heart Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-831$350
   Table 27: World 14-Year Perspective for Heart Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-841$350
   Table 28: World Recent Past, Current & Future Analysis for Kidney Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-851$350
   Table 29: World Historic Review for Kidney Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-861$350
   Table 30: World 14-Year Perspective for Kidney Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-871$350
   Table 31: World Recent Past, Current & Future Analysis for Liver Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-881$350
   Table 32: World Historic Review for Liver Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-891$350
   Table 33: World 14-Year Perspective for Liver Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-901$350
   Table 34: World Recent Past, Current & Future Analysis for Pancreas Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-911$350
   Table 35: World Historic Review for Pancreas Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-921$350
   Table 36: World 14-Year Perspective for Pancreas Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-931$350
   Table 37: World Recent Past, Current & Future Analysis for Lung Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-941$350
   Table 38: World Historic Review for Lung Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-951$350
   Table 39: World 14-Year Perspective for Lung Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-961$350
   Table 40: World Recent Past, Current & Future Analysis for Corneal Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-971$350
   Table 41: World Historic Review for Corneal Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-981$350
   Table 42: World 14-Year Perspective for Corneal Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-991$350
   A. Market Analysis.....III-1
Current & Future Analysis.....III-1
Organ Transplant Sector Holds Growth Potential.....III-1
1$75
   Table 43: US Organ Donors by Type - Kidney, Liver, Heart, Lung, and Pancreas for the Years 2014, 2015 and 2016 (includes corresponding Graph/Chart).....III-21$200
   Table 44: The US Bone Marrow Donor Registry: Percentage Breakdown of Adult Donors and Cord Blood Units by Race/Ethnicity (includes corresponding Graph/Chart).....III-31$200
   Table 45: The US Kidney Donations by Donor Type (Deceased and Living): Number of Donors for 2014, 2015 and 2016 (includes corresponding Graph/Chart).....III-4

Table 46: The US Liver Donations by Donor Type (Deceased and Living): Number of Donors for 2014, 2015 and 2016 (includes corresponding Graph/Chart).....III-4
1$200
   Table 47: The US Heart Donations by Donor Type - Deceased and Living: Number of Donors for 2014, 2015 and 2016 (includes corresponding Graph/Chart).....III-5

Table 48: The US Lung Donations by Donor Type - Deceased and Living: Number of Procedures for 2014, 2015 and 2016 (includes corresponding Graph/Chart).....III-5
1$200
   Table 49: The US Pancreas Donations by Donor Type - Deceased and Living: Number of Procedures for 2014, 2015 and 2016 (includes corresponding Graph/Chart).....III-6

Table 50: The US Intestines Donations by Donor Type - Deceased and Living: Number of Procedures for 2014, 2015 and 2016 (includes corresponding Graph/Chart).....III-6
1$200
   Table 51: The US Intestinal Transplants by Donor Type - Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2014, 2015 and 2016 (includes corresponding Graph/Chart).....III-7

Table 52: The US Deceased Organ Donors (2016): Percentage Breakdown of Donors by Age Group (includes corresponding Graph/Chart).....III-7
1$200
   Table 53: The US Live Organ Donors (2016): Percentage Breakdown of Donors by Age Group (includes corresponding Graph/Chart).....III-8

Table 54: The US Organ Transplant Market by Race (2015): Percentage Breakdown of Donors and Recipients for African-Americans, Caucasians, Hispanics and Others (includes corresponding Graph/Chart).....III-8
Waiting List for Organ Transplants in the US.....III-8
1$200
   Table 55: Waiting List of Patients for Organ Transplants in the US by Organ Type: As of November, 2016 (includes corresponding Graph/Chart).....III-9
Select Market Trends.....III-9
Rising Incidence of ESRD in the US: A Business Case for Kidney Transplants.....III-9
1$200
   Table 56: ESRD Patient Prevalence in the US (2009-2014) (includes corresponding Graph/Chart).....III-101$200
   Innovative Education Programs Contribute to Higher Organ Donors.....III-11
Awareness Programs to Address Shortage of Minority Donors.....III-11
1$75
   US Organ Procurement Organizations by State.....III-121$75
   KPD Enables Compatibility Factor for Kidney Transplants.....III-13
Tissue Transplantation in the US.....III-13
1$75
   Dental Bone Graft Substitutes Market: An Overview.....III-14
Regulatory Challenges Limit Growth in the US Orthopedic Biomaterials
  Market.....III-14
Rising Incidence of Degenerative Intervertebral Disc Diseases - Opportunity
  Indicators for Bone Grafts.....III-14
1$75
   Osteoporosis.....III-15
Table 57: Osteoporosis Population in the US: 2002, 2005, 2008 & 2012 (includes corresponding Graph/Chart).....III-15

Table 58: Breakdown of Osteoporotic Fractures by Site in the US (includes corresponding Graph/Chart).....III-15
1$200
   Regulatory Bodies.....III-16
The United Network for Organ Sharing.....III-16
The American Association of Tissue Banks (AATB).....III-16
Accredited Banks from Select US States.....III-16
2$150
   Eye Banks from Select US States.....III-181$75
   National Organ Transplant Act (NOTA).....III-19
Good Tissue Practices.....III-19
Tissue Banking Regulation.....III-19
FDA Regulations on Xenograft.....III-19
DBM-based Products in US.....III-19
1$75
   Synthetic Bone Graft Substitutes.....III-20
Strategic Corporate Developments.....III-20
3$225
   Select Key Players.....III-233$225
   B. Market Analytics.....III-26
By Value Sales.....III-26
Table 59: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-26
1$200
   Table 60: The US Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-271$200
   Table 61: The US 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Dollar Sales for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-281$200
   Table 62: The US Recent Past, Current & Future Analysis for Cornea Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-291$200
   Table 63: The US Historic Review for Cornea Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-301$200
   By Number of Procedures.....III-31
Table 64: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-31
1$200
   Table 65: The US Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-321$200
   Table 66: The US 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-331$200
   Table 67: The US Recent Past, Current & Future Analysis for Tissue Transplantation by Tissue Type - Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-341$200
   Table 68: The US Historic Review for Tissue Transplantation by Tissue Type - Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-351$200
   Table 69: The US 14-Year Perspective for Tissue Transplantation by Tissue Type - Percentage Breakdown of Number of Procedures for Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-361$200
   Table 70: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Graft Type - Autologous Graft, Allograft and Other Materials Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-371$200
   Table 71: The US Historic Review for Bone Graft Transplantation by Graft Type - Autologous Graft, Allograft and Other Materials Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-381$200
   Table 72: The US 14-Year Perspective for Bone Graft Transplantation by Graft Type - Percentage Breakdown of Number of Procedures for Autologous Graft, Allograft and Other Materials Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-391$200
   Table 73: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Application - General Orthopedics, Spinal Fusions and Cranio/Maxillofacial Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-401$200
   Table 74: The US Historic Review for Bone Graft Transplantation by Application - General Orthopedics, Spinal Fusions and Cranio/ Maxillofacial Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-411$200
   Table 75: The US 14-Year Perspective for Bone Graft Transplantation by Application - Percentage Breakdown of Number of Procedures for General Orthopedics, Spinal Fusions and Cranio/ Maxillofacial Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-421$200
   A. Market Analysis.....III-43
Current & Future Analysis.....III-43
Canadians More Receptive to Organ Transplants.....III-43
Table 76: Canadian Transplantation Market by Organ (2014): Percentage Breakdown of Number of Procedures for Hearts, Kidneys, Liver, Lungs and Pancreas (includes corresponding Graph/Chart).....III-43
1$200
   Table 77: Canadian Organ Donors by Donor Type - Deceased and Living for Years 2011 - 2014 (includes corresponding Graph/Chart).....III-441$200
   Table 78: Canadian Deceased Organ Donors by Age Group (2011-2014) (includes corresponding Graph/Chart).....III-451$200
   Table 79: Canadian Living Organ Donors by Age Group (2011-2014) (includes corresponding Graph/Chart).....III-461$200
   Waiting List.....III-47
Table 80: Canadian Patients on Active Waiting List for Organ Transplants by Type: 2014 (includes corresponding Graph/Chart).....III-47
Success Rate of Organ Transplants.....III-47
Table 81: Success Rate of Organ Transplants after 1-Year (includes corresponding Graph/Chart).....III-47
Favorable Growth Prospects in Bone Graft Substitutes Market.....III-47
1$200
   B. Market Analytics.....III-48
Table 82: Canadian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-48
1$200
   Table 83: Canadian Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-491$200
   Table 84: Canadian 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-501$200
   A. Market Analysis.....III-51
Current & Future Analysis.....III-51
Terumo Corporation (Japan) – A Key Player.....III-51
1$75
   B. Market Analytics.....III-52
Table 85: Japanese Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-52
1$200
   Table 86: Japanese Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-531$200
   Table 87: Japanese 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-541$200
   A. Market Analysis.....III-55
Current & Future Analysis.....III-55
Table 88: European Deceased Organ Donors Per Million Population (PMP) in Select Leading Countries: 2013 & 2014 (includes corresponding Graph/Chart).....III-55
1$200
   Table 89: European Multi-Organ Donors in Select Leading Countries: 2013 & 2014 (includes corresponding Graph/Chart).....III-56

Table 90: European Living Organ Donor Per Million Population (PMP) by Country for 2013 & 2014 (includes corresponding Graph/Chart).....III-56
1$200
   Table 91: European Organ Transplantation by Organ in Select Leading Countries: 2014 (includes corresponding Graph/Chart).....III-571$200
   Table 92: European Organ Transplantation Waiting Lists: No. of Waiting Patients by Organ Type (As of Month End - October 2015 and 2016) (includes corresponding Graph/Chart).....III-581$200
   Table 93: European Organ Transplantation Waiting List by Organ in Select Leading Countries: 2014 (includes corresponding Graph/Chart).....III-591$200
   Policy Changes – Key to Bridge Variability in Kidney Donors and Transplants
  across Europe.....III-60
Focus on Select Regions.....III-60
The United Kingdom.....III-60
The UK Organ Transplantation System: An Overview.....III-60
1$75
   Table 94: Organ Donation in the UK by Type: Number of Deceased and Living Donors for Years 2013-14 through 2016-17 (includes corresponding Graph/Chart).....III-611$200
   Table 95: Organ Donation in the UK by Country (2013-14 through 2016-17): Number of Donors by Type for England, Scotland, Norther Ireland and Wales (includes corresponding Graph/Chart).....III-621$200
   Table 96: UK Organ Transplantation Market: Number of Transplants by Donor Type for Years 2013-14 through 2016-17 (includes corresponding Graph/Chart).....III-631$200
   Table 97: UK Deceased Donor Organ Transplants: Number of Transplants by Organ Type for Years 2013-14 through 2015-16 (includes corresponding Graph/Chart).....III-641$200
   Table 98: UK Organ Transplantation Market by Country (2013-14 through 2016-17): Number of Transplants by Type for England, Scotland, Norther Ireland and Wales (includes corresponding Graph/Chart).....III-651$200
   Table 99: UK Organ Transplantation Waiting List: 2013-14 through 2016-17 (includes corresponding Graph/Chart).....III-661$200
   Table 100: UK Organ Transplant Waiting List by Organ Types: 2014-15 through 2016-17 (includes corresponding Graph/Chart).....III-671$200
   Table 101: Organ Donation in the UK (2015): Percentage Breakdown of Number of Donors by Age Group (includes corresponding Graph/Chart).....III-68
Spain.....III-68
Organ Transplantation in Spain.....III-68
France.....III-68
1$200
   Italy.....III-69
Surge in Organ Transplants.....III-69
Russia.....III-69
Organ Transplantations Show a Downward Trend in Russia.....III-69
Turkey.....III-69
Table 102: Turkey - High PMP Numbers of Living Organ Donors/Transplants (includes corresponding Graph/Chart).....III-69
1$200
   Akdeniz University – A World-Renowned Transplantation Center.....III-70
Strategic Corporate Developments.....III-70
Select Key Players.....III-70
2$150
   B. Market Analytics.....III-72
Table 103: European Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-72
1$200
   Table 104: European Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-731$200
   Table 105: European 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-741$200
   A. Market Analysis.....III-75
Current & Future Analysis.....III-75
Table 106: Asia-Pacific Deceased Organ Donor Per Million Population (PMP) by Country for 2013 & 2015 (includes corresponding Graph/Chart).....III-75

Table 107: Asia-Pacific Living Organ Donor Per Million Population (PMP) by Country for 2011, 2013 & 2015 (includes corresponding Graph/Chart).....III-75
1$200
   Thriving Orthopedic Biomaterials Market in Asia-Pacific.....III-76
Focus on Select Regions.....III-76
Australia – One of the Major Organ Transplant Markets in Asia-Pacific.....III-76
Key Facts on Organ and Tissue Transplantation in Australia.....III-76
Organ Transplantations Reach Record Highs.....III-76
1$75
   Table 108: Organ Donors in Australia by Type: Number of Consented and Actual Donors Years 2009, 2012 & 2015 (includes corresponding Graph/Chart).....III-771$200
   Table 109: Organ Transplantation in Australia: Number of Organ Recipients and Transplantations for Years 2009 through 2015 (includes corresponding Graph/Chart).....III-78

Table 110: Organ Transplantation in Australia by Organ Type (2015): Number of Transplants for Heart, Kidney, Liver, Lung and Pancreas (includes corresponding Graph/Chart).....III-78
1$200
   Table 111: Organ Transplantation Waiting in Australia by Organ Type: 2014 (includes corresponding Graph/Chart).....III-79

Table 112: Australian Organ Transplants by State: 2015 (includes corresponding Graph/Chart).....III-79
1$200
   Table 113: Live Tissue Donations in Australia by Type (2013-2015): Number of Donations for Cardiovascular and Musculoskeletal Tissues (includes corresponding Graph/Chart).....III-80

Table 114: Deceased Tissue Donations in Australia by Type (2013-2015): Number of Organ & Tissue, and Tissue Only Donations for Cardiovascular, Musculoskeletal, Pancreas and Skin Tissues (includes corresponding Graph/Chart).....III-80
1$200
   Government Efforts Key for Improving Organ Donation Activity.....III-81
Government Mulls Easing Registration Process Further.....III-81
China.....III-81
Chinese Organ Transplant Market – Embroiled in Controversy.....III-81
1$75
   Transplantation Tourism in China.....III-821$75
   Low Transplant Success Rate Due to Unskilled Professionals.....III-83
Illegal Activities for Harvesting Organs in China.....III-83
Regulations on Organ Transplantation.....III-83
1$75
   Regulations on Brain Death.....III-84
India.....III-84
Organ Transplantation in India – Present Status.....III-84
Table 115: Indian Organ Transplantation Market (2015): Current Requirement in Number of Organs by Type (includes corresponding Graph/Chart).....III-84
1$200
   Table 116: Indian Organ Transplantation Market (2015): Number of Transplantations by Organ Type (includes corresponding Graph/Chart).....III-85
Rise in Medical Tourism Drives Bone Grafts Market.....III-85
Aging Population Boosts the Indian Orthopedic Market.....III-85
Overview of Renal Transplantation.....III-85
1$200
   Structural Deficiencies Affecting Indian Organ Donation Space.....III-86
Singapore.....III-86
Awareness Programs to Increase Living Kidney Donations in Singapore.....III-86
1$75
   Strategic Corporate Developments.....III-871$75
   B. Market Analytics.....III-88
Table 117: Asia-Pacific Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-88
1$200
   Table 118: Asia-Pacific Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-891$200
   Table 119: Asia-Pacific 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-901$200
   A. Market Analysis.....III-91
Current & Future Analysis.....III-91
Brazil – A Major Transplant Market.....III-91
Dental Bone Graft Substitutes Market – Overview.....III-91
1$75
   Key Statistics.....III-92
Table 120: Latin American Deceased Organ Donors Per Million Population (PMP) in Select Leading Countries: 2013 & 2014 (includes corresponding Graph/Chart).....III-92

Table 121: Latin American Multi-Organ Donors in Select Leading Countries: 2013 & 2014 (includes corresponding Graph/Chart).....III-92
1$200
   Table 122: Latin American Living Organ Donor Per Million Population (PMP) by Country: 2013 & 2014 (includes corresponding Graph/Chart).....III-931$200
   Table 123: Latin American Organ Transplantation by Organ in Select Leading Countries: 2014 (includes corresponding Graph/Chart).....III-941$200
   Table 124: Latin American Organ Transplantation Waiting List by Organ in Select Leading Countries: 2014 (includes corresponding Graph/Chart).....III-951$200
   B. Market Analytics.....III-96
Table 125: Latin American Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-96
1$200
   Table 126: Latin American Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-971$200
   Table 127: Latin American 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-981$200
   Market Analysis.....III-99
Table 128: Rest of World Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-99
1$200
   Table 129: Rest of World Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1001$200
   Table 130: Rest of World 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1011$200
  
Total Companies Profiled: 22 

Region/Country Players

The United States 18 Europe 4 Germany 1 Rest of Europe 3
Click here to request a full table of contents and more details on this project.